Drug Shortage Report for ATACAND
Report ID | 105632 |
Drug Identification Number | 02311658 |
Brand name | ATACAND |
Common or Proper name | candesartan cilexetil |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | CANDESARTAN CILEXETIL |
Strength(s) | 32MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 tablets |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-02-12 |
Actual start date | 2020-02-12 |
Estimated end date | 2020-03-27 |
Actual end date | 2020-03-25 |
Shortage status | Resolved |
Updated date | 2020-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2020-03-26 | French | Compare |
v8 | 2020-03-26 | English | Compare |
v7 | 2020-02-13 | French | Compare |
v6 | 2020-02-13 | English | Compare |
v5 | 2020-02-13 | English | Compare |
v4 | 2020-02-10 | French | Compare |
v3 | 2020-02-10 | English | Compare |
v2 | 2020-02-10 | French | Compare |
v1 | 2020-02-10 | English | Compare |
Showing 1 to 9 of 9